Tuesday § December 23, 2008
Medical Publisher Looks into Lawmaker’s Allegation of Misrepresentation
The NYT is reporting that, because mainly of allegations made by Sen. Charles Grassley (R-IA), a medical publishing company plans to investigate an article “improperly” ghostwritten by pharma giant Wyeth to promote its patented estrogen, Prempro. Medical ghostwriting is not a new practice. It’s merely just another promotional tool in marketing a pharma company’s product, end user beware. The problem arises, however, when the ugly spectre of misrepresentation occurs. Intentional or apparent? | LINK
Related Posts Within Doctor Pundit:
- Supreme Court Ruling Offers Admonition to Big Pharma In a recent SCOTUS ruling, the high court decided 6-3 (Alito,...
- Medical Student Org Publicizes Medical Schools’ Pharma Policies In a way, the “predation” of pharma companies on medical...
- Iowa Senator Continues Investigation into Medical Ghostwriting To Senator Charles Grassley (R-IA) ghostwriting and plagiarism fall within...
Doctor Pundit is now on the proprietary Amazon e-reader, the Kindle. Do you own one? Consider getting each and every post delivered wirelessly. Don't miss a single health policy moment. 